Les publications du Groupe de travail

2024

Cutaneous hybrid cysts with matrical differentiation are mostly sporadic and related to CTNNB1 mutation.
Bach CLT, Tallet A, Bonenfant C, Lecomte T, Piton N, Samimi M, Guyétant S, Kervarrec T. Virchows Arch. 2024 Nov 23. doi: 10.1007/s00428-024-03986-3. Online ahead of print. PMID: 39579263

Recurrent GRHL fusions in a subset of sebaceoma: microscopic and molecular characterisation of eight cases.
Legrand M, Louveau B, Macagno N, Mancini M, Kazakov DV, Pissaloux D, Tirode F, Tallet A, Mourah S, Lepiller Q, de la Fouchardière A, Sohier P, Frouin E, von Deimling A, Goto K, Cribier B, Calonje E, Taibjee S, Battistella M, Kervarrec T. Histopathology. 2024 Nov 20. doi: 10.1111/his.15361. Online ahead of print. PMID: 39564735

Re-evaluation of the concept of basaloid follicular hamartoma associated with naevoid basal cell carcinoma syndrome: a morphological, immunohistochemical and molecular study.
Barbieux S, Jouenne F, Machet MC, Fraitag S, Macagno N, Battistella M, Cribier B, Sohier P, Laurent-Roussel S, Carlotti A, Beltzung F, Jullié ML, Moulonguet I, Basset-Seguin N, Deschamps L, Mourah S, Samimi M, Guyétant S, Kervarrec T. Pathology. 2024 Sep 17:S0031-3025(24)00230-7. doi: 10.1016/j.pathol.2024.06.013. Online ahead of print. PMID: 39455322

YAP1::NR4A3 and YAP1::NCOA2 fusions in poroma: expanding the spectrum of molecular alterations in poroid tumors.
Secco LP, Libbrecht L, Bonny M, Lepine C, Švajdler M, Tallet A, Chantreau PL, Cormier B, Cribier B, Siozopoulou V, Kervarrec T. Virchows Arch. 2024 Oct;485(4):749-753. doi: 10.1007/s00428-024-03898-2. Epub 2024 Aug 23. PMID: 39222124

Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database.
Mortier L, Blom A, van Hille B, Samimi M, Luciani L, Cahuzac C, Robert C, Quereux G, Maubec E, Miotti H, Maillard C, Aubin F, Lenormand C, Solbes MN, Joly P, Kachaner I, Lebbé C, Dutriaux C, Saiag P. Eur J Cancer. 2024 Sep;209:114261. doi: 10.1016/j.ejca.2024.114261. Epub 2024 Aug 3. PMID: 39128185

Wnt/β-Catenin-Activated Nonpilomatrical Carcinoma of the Skin: A Case Series.
Kervarrec T, Cheok Lei K, Sohier P, Macagno N, Jullie ML, Frouin E, Goto K, Taniguchi K, Hamard A, Taillandier A, Tallet A, Bonenfant C, Sahin Y, Barry F, Taibjee S, Cokelaere K, Houben R, Schrama D, Nardin C, Aubin F, Doucet L, Pissaloux D, Tirode F, Fouchardière A, Balme B, Laurent-Roussel S, Becker JC, von Deimling A, Samimi M, Cribier B, Battistella M, Calonje E, Guyétan S. Mod Pathol. 2024 Nov;37(11):100586. doi: 10.1016/j.modpat.2024.100586. Epub 2024 Jul 31. PMID: 39094735

Neoadjuvant Sonic Hedgehog Inhibitors Combined With Radiotherapy Is a Promising Strategy for Locally Advanced Basal Cell Carcinoma.
Boileau M, Taillez A, Lemoine P, Dubois M, Mortier L, Mirabel X. J Clin Oncol. 2024 Nov 10;42(32):3882-3883. doi: 10.1200/JCO.24.01042. Epub 2024 Aug 2. PMID: 39094064

Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation.
Kervarrec T, Appenzeller S, Gramlich S, Coyaud E, Bachiri K, Appay R, Macagno N, Tallet A, Bonenfant C, Lecorre Y, Kapfer J, Kettani S, Srinivas N, Lei KC, Lange A, Becker JC, Sarosi EM, Sartelet H, von Deimling A, Touzé A, Guyétant S, Samimi M, Schrama D, Houben R. J Pathol. 2024 Sep;264(1):112-124. doi: 10.1002/path.6304. Epub 2024 Jul 25. PMID: 39049595

Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.
Zagala R, Dalle S, Beylot-Barry M, Meyer N, Saiag P, Kramkimel N, Lebbe C, Zehou O, Amini-Adle M, Grob JJ, Arnault JP, Maubec E, Granel-Brocard F, Cribier B, Quereux G, Brunet-Possenti F, Dalac S, Dereure O, Drumez E, Mortier L, Battistella M, Jouary T. J Eur Acad Dermatol Venereol. 2024 Jun 12. doi: 10.1111/jdv.20155. Online ahead of print. PMID: 38864258

[Cutaneous adnexal tumours: Development and synthesis of diagnostic fusion genes].
Kervarrec T, Battistella M, Macagno N. Ann Pathol. 2024 Jun 4:S0242-6498(24)00118-4. doi: 10.1016/j.annpat.2024.05.002. Online ahead of print. PMID: 38839526

Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high-throughput sequencing approach.
Louveau B, Nakouri I, Jouenne F, Baroudjian B, Sadoux A, Da Meda L, Osio A, Reinhart F, Robert J, Herms F, Cribier B, Mortier L, Jouary T, Basset Seguin N, Lebbé C, Mourah S, Battistella M. Br J Dermatol. 2024 Sep 18;191(4):639-641. doi: 10.1093/bjd/ljae233. PMID: 38836587

OGT::FOXO1-fused myoepithelioma-like hyalinising epithelioid tumour arising in non-acral skin.
Legrand M, Tallet A, Bonenfant C, Thanguturi S, de Pinieux G, Kervarrec T. Pathology. 2024 Oct;56(6):915-918. doi: 10.1016/j.pathol.2024.03.002. Epub 2024 May 6. PMID: 38816310

Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
Lugowska I, Becker JC, Ascierto PA, Veness M, Blom A, Lebbe C, Migliano E, Hamming-Vrieze O, Goebeler M, Kneitz H, Nathan P, Rutkowski P, Slowinska M, Schadendorf D, Piulats JM, Petrelli F, van Akkooi ACJ, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. ESMO Open. 2024 May;9(5):102977. doi: 10.1016/j.esmoop.2024.102977. Epub 2024 Apr 30. PMID: 38796285

Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
Kervarrec T, Westphal D, Pissaloux D, Legrand M, Tirode F, Neuhart A, Drouot F, Becker JC, Macagno N, Seris A, Jouary T, Beltzung F, Jullie ML, Harms PW, Cribier B, Mourah S, Jouenne F, Fromont G, Louveau B, Mancini M, Kazakov DV, de la Fouchardière A, Battistella M. Histopathology. 2024 Oct;85(4):566-578. doi: 10.1111/his.15214. Epub 2024 May 24. PMID: 38785043

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.
D'Angelo SP, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Prinzi N, Hanna GJ, Hassel JC, Kiecker F, von Heydebreck A, Güzel G, Nghiem P. ESMO Open. 2024 May;9(5):103461. doi: 10.1016/j.esmoop.2024.103461. Epub 2024 May 13. PMID: 38744102

Nuclear pseudoinclusions as a clue for NUTM1-rearranged poroid tumours recognition.
Taillandier A, Legrand M, Petereau A, Tallet A, Collin C, Frouin E, Jullie ML, Macagno N, Battistella M, Kervarrec T. Histopathology. 2024 Aug;85(2):362-365. doi: 10.1111/his.15208. Epub 2024 May 7. PMID: 38715411

Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma.
Leroy M, Desmedt E, Deramoudt L, Vasseur M, Odou P, Béhal H, Décaudin B, Mortier L, Simon N. Melanoma Res. 2024 Jun 1;34(3):258-264. doi: 10.1097/CMR.0000000000000965. Epub 2024 Mar 15. PMID: 38489575

Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma.
Boileau M, Dubois M, Pruvot C, Desmedt E, Templier C, Meyer N, Mirabel X, Mortier L. Clin Exp Dermatol. 2024 Aug 22;49(9):1024-1028. doi: 10.1093/ced/llae068. PMID: 38440960

SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.
Macagno N, Kervarrec T, Thanguturi S, Sohier P, Pissaloux D, Mescam L, Jullie ML, Frouin E, Osio A, Faisant M, Le Loarer F, Cribier B, Calonje E, Luna EVE, Massi D, Goto K, Nishida H, Paindavoine S, Houlier A, Tantot J, Benzerdjeb N, Tirode F, De la Fouchardière A, Battistella M. Mod Pathol. 2024 Mar;37(3):100430. doi: 10.1016/j.modpat.2024.100430. Epub 2024 Jan 23. PMID: 38266920

Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinoma.
Kervarrec T, Appenzeller S, Tallet A, Jullie ML, Sohier P, Guillonneau F, Rütten A, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Beneton N, Bens G, Nardin C, Aubin F, Dinulescu M, Visée S, Herfs M, Touzé A, Guyétant S, Samimi M, Houben R, Schrama D. Histopathology. 2024 Jan;84(2):356-368. doi: 10.1111/his.15068. Epub 2023 Oct 13. PMID: 37830288

Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
Kervarrec T, Pissaloux D, Tirode F, de la Fouchardière A, Sohier P, Frouin E, Hamard A, Houben R, Schrama D, Barlier A, Cribier B, Battistella M, Macagno N. Histopathology. 2024 Jan;84(2):266-278. doi: 10.1111/his.15023. Epub 2023 Aug 23. PMID: 37609771

2023

Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey.
Kervarrec T, Tallet A, Macagno N, de la Fouchardière A, Pissaloux D, Tirode F, Bravo IG, Nicolas A, Baulande S, Sohier P, Balme B, Osio A, Jullie ML, Moulonguet I, Bonsang B, Tournier E, Herfs M, Frouin E, Zidan A, Calonje E, Berthon P, Touzé A, Seris A, Mortier L, Jouary T, Cribier B, Battistella M. Am J Surg Pathol. 2023 Oct 1;47(10):1096-1107. doi: 10.1097/PAS.0000000000002098. Epub 2023 Jul 31. PMID: 37505808

Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.
Kervarrec T, Imbeaud S, Veyer D, Pere H, Puech J, Pekár-Lukacs A, Markiewicz D, Coutts M, Tallet A, Collin C, Berthon P, Bravo IG, Seris A, Jouary T, Macagno N, Touzé A, Cribier B, Battistella M, Calonje E. Am J Surg Pathol. 2023 Oct 1;47(10):1077-1084. doi: 10.1097/PAS.0000000000002096. Epub 2023 Jul 31. PMID: 37505796

SSTR2A is a diagnostic marker of trichogerminoma.
Legrand M, Pissaloux D, Tirode F, Tallet A, Collin C, Chantreau PL, Berthon P, Jullie ML, Sohier P, Calonje E, Luzar B, Moulonguet I, Goto K, Cokelaere K, Lamant L, Balme B, Deschamps L, Macagno N, Cribier B, Battistella M, de la Fouchardière A, Kervarrec T. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1344-e1347. doi: 10.1111/jdv.19319. Epub 2023 Jul 11. PMID: 37421254

Genetics of adnexal tumors: An update.
Kervarrec T, Sohier P, Pissaloux D, de la Fouchardiere A, Cribier B, Battistella M, Macagno N. Ann Dermatol Venereol. 2023 Sep;150(3):202-207. doi: 10.1016/j.annder.2023.03.003. Epub 2023 Jun 1. PMID: 37270318

Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.
Kervarrec T, Pissaloux D, Paindavoine S, Tirode F, Osio A, Mourah S, Jouenne F, Sohier P, Calonje E, Pekar A, Luna EVE, Goto K, Delalande F, Frouin E, Macagno N, Drouot F, Faisan M, Cribier B, Battistella M, de la Fouchardière A. Histopathology. 2023 Aug;83(2):310-319. doi: 10.1111/his.14940. Epub 2023 May 18. PMID: 37199682

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.
Toulemonde E, Chevret S, Battistella M, Neidhardt EM, Nardin C, Le Du F, Meyer N, Véron M, Gambotti L, Lamrani-Ghaouti A, Jamme P, Chaffaut C, De Pontville M, Saada-Bouzid E, Beylot-Barry M, Simon C, Jouary T, Marabelle A, Mortier L. Cancer Immunol Immunother. 2023 Aug;72(8):2649-2657. doi: 10.1007/s00262-023-03449-9. Epub 2023 Apr 17. PMID: 37067554

Acral BRAF-mutated tubular adenoma should be distinguished from HPV42-related digital papillary adenocarcinoma.
Kervarrec T, Busam KJ. J Cutan Pathol. 2023 Jun;50(6):577-579. doi: 10.1111/cup.14430. Epub 2023 Apr 14. PMID: 37057379

Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.
Durand MA, Drouin A, Mouchard A, Durand L, Esnault C, Berthon P, Tallet A, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Saiag P, Beneton N, Bens G, Nardin C, Aubin F, Dinulescu M, Collin C, Fromont-Hankard G, Cribier B, Laurent-Roussel S, Cokelaere K, Houben R, Schrama D, Peixoto P, Hervouet E, Bachiri K, Kantar D, Coyaud E, Guyétant S, Samimi M, Touzé A, Kervarrec T. J Invest Dermatol. 2023 Oct;143(10):1937-1946.e7. doi: 10.1016/j.jid.2023.02.038. Epub 2023 Apr 8. PMID: 37037414

Microsecretory adenocarcinoma of the skin, a novel type of sweat gland carcinoma: Report of three additional cases.
Bogiatzi S, Estenaga A, Louveau B, Osio A, Deschamps L, Mourah S, Poirot B, Lehmann-Che J, Cribier B, Battistella M. J Cutan Pathol. 2023 Oct;50(10):897-902. doi: 10.1111/cup.14408. Epub 2023 Mar 8. PMID: 36790018

Diagnostic Accuracy of GATA6 Immunostaining in Sebaceous Tumors of the Skin.
Oulès B, Deschamps L, Sohier P, Tihy M, Chassac A, Couvelard A, Frouin E, Battistella M. Mod Pathol. 2023 Apr;36(4):100101. doi: 10.1016/j.modpat.2023.100101. Epub 2023 Jan 18. PMID: 36788082

Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
Kervarrec T, Frouin E, Collin C, Tallet A, Tallegas M, Pissaloux D, Tirode F, Guyétant S, Samimi M, Gaboriaud P, Touzé A, Schrama D, Houben R, Tabareau-Delalande F, Neuhart A, de la Fouchardière A, Osio A, Cavelier-Balloy B, Laurent-Roussel S, Sohier P, Cyprien T, Balme B, Belzung F, Jullie ML, Cribier B, Battistella M, Macagno N. Histopathology. 2023 May;82(6):885-898. doi: 10.1111/his.14874. Epub 2023 Feb 22. PMID: 36720791

Superficial spindle cell tumour with TNC::PDGFD fusion is a distinct entity from dermatofibrosarcoma protuberans.
Legrand M, Tallegas M, Coeugnet A, Macagno N, Jullié ML, Kervarrec T. Pathology. 2023 Jun;55(4):562-564. doi: 10.1016/j.pathol.2022.08.008. Epub 2022 Oct 15. PMID: 36351867

2022

Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Véron M, Chevret S, Grob JJ, Beylot-Barry M, Saiag P, Fléchon A, You B, Maubec E, Jouary T, Toulemonde E, Jamme P, Gambotti L, Lamrani-Ghaouti A, Dupuy A, Lebbe C, Seguin NB, Houede N, Leccia MT, Le Du F, de Pontville M, Gaudy-Marquestre C, Guillot B, Simon C, Marabelle A, Mortier L. Eur J Cancer. 2022 Dec;177:103-111. doi: 10.1016/j.ejca.2022.09.013. Epub 2022 Oct 11. PMID: 36335780

CD5 expression in Merkel cell carcinoma and extracutaneous neuroendocrine carcinomas.
Legrand M, Tallet A, Guyétant S, Samimi M, Ortonne N, Kervarrec T. Pathology. 2023 Feb;55(1):141-143. doi: 10.1016/j.pathol.2022.04.007. Epub 2022 Jul 11. PMID: 35835644

Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinoma.
Thanguturi S, Tallet A, Miquelestorena-Standley E, Coco C, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Saiag P, Beneton N, Bens G, Zaragoza J, Nardin C, Aubin F, Dinulescu M, Machet MC, Houben R, Schrama D, Collin C, Fromont G, Jullie ML, Macagno N, Gaboriaud P, Berthon P, Touzé A, Guyétant S, Samimi M, Kervarrec T. Virchows Arch. 2022 Jun;480(6):1239-1254. doi: 10.1007/s00428-022-03315-6. Epub 2022 Apr 12. PMID: 35412101

Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors.
Macagno N, Sohier P, Kervarrec T, Pissaloux D, Jullie ML, Cribier B, Battistella M. Cancers (Basel). 2022 Jan 18;14(3):476. doi: 10.3390/cancers14030476. PMID: 35158743

Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.
Battistella M, Balme B, Jullie ML, Zimmermann U, Carlotti A, Crinquette M, Frouin E, Macagno N, Ortonne N, Lamant L, de la Fouchardiere A, Aubriot-Lorton MH, Durand L, Josselin N, Franck F, Chatelain D, Lemasson G, Algros MP, Durlach A, Machet MC, Courville P, Osio A, Seris A, Mortier L, Jouary T, Cribier B; CARADERM network. Eur J Cancer. 2022 Mar;163:211-221. doi: 10.1016/j.ejca.2021.11.027. Epub 2022 Jan 30. PMID: 35090811

Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma.
Kervarrec T, Pissaloux D, Poilane J, Tirode F, Tallet A, Collin C, Tallegas M, Berthon P, Gaboriaud P, Sohier P, Calonje E, Luzar B, Goto K, Cokelaere K, Lamant L, Balme B, Wild R, Neuville A, Deschamps L, Auberger E, Paumier V, Bonte H, Moulonguet I, Plantier F, Cales V, Pinsolle V, Roblet D, Dupuy F, Dallot A, Seris A, Jouary T, Houben R, Schrama D, Hesbacher S, Macagno N, Battistella M, Cribier B, Vergier B, de la Fouchardière A, Jullie ML. J Pathol. 2022 May;257(1):96-108. doi: 10.1002/path.5872. Epub 2022 Mar 28. PMID: 35049062

Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine Differentiation.
Kervarrec T, Appenzeller S, Samimi M, Sarma B, Sarosi EM, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Benethon N, Bens G, Nardin C, Aubin F, Dinulescu M, Jullie ML, Pekár-Lukacs Á, Calonje E, Thanguturi S, Tallet A, Wobser M, Touzé A, Guyétant S, Houben R, Schrama D. J Invest Dermatol. 2022 Mar;142(3 Pt A):516-527. doi: 10.1016/j.jid.2021.07.175. Epub 2021 Sep 1. PMID: 34480892

2021

Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database.
Bassompierre A, Dalac S, Dreno B, Neidhardt EM, Maubec E, Capelle C, Andre F, Behal H, Dziwniel V, Bens G, Leccia MT, Meyer N, Granel-Brocard F, Beylot-Barry M, Dereure O, Basset-Seguin N, Mortier L. ESMO Open. 2021 Dec;6(6):100284. doi: 10.1016/j.esmoop.2021.100284. Epub 2021 Oct 21. PMID: 34689002

Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors.
Monnet P, Herms F, Djermane M, Dalac S, Dereure O, Dréno B, Beylot-Barry M, Mortier L, Basset-Seguin N. Br J Dermatol. 2022 Mar;186(3):579-581. doi: 10.1111/bjd.20808. Epub 2021 Nov 24. PMID: 34817864

Reply to: Expanding the Spectrum of Primary Cutaneous Carcinoma With BRD3-NUTM1 Fusion.
Kervarrec T, Amatore F, Pissaloux D, Paindavoine S, Legrand E, Lehmann-Che J, Battistella M, Macagno N. Am J Surg Pathol. 2021 Nov 1;45(11):1584-1586. doi: 10.1097/PAS.0000000000001796. PMID: 34469332

Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
Ascierto PA, Orlova K, Grignani G, Dudzisz-Śledź M, Fenig E, Chiarion Sileni V, Fazio N, Samimi M, Mortier L, Gebhardt C, Kramkimel N, Steven N, Bechter O, Arance A, Benincasa E, Kostkova L, Costa N, Lorigan P. Int J Cancer. 2021 Dec 1;149(11):1926-1934. doi: 10.1002/ijc.33746. Epub 2021 Aug 3. PMID: 34310716

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
D'Angelo SP, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Prinzi N, Hanna GJ, Hassel JC, Kiecker F, Georges S, Ellers-Lenz B, Shah P, Güzel G, Nghiem P. J Immunother Cancer. 2021 Jul;9(7):e002646. doi: 10.1136/jitc-2021-002646. PMID: 34301810

Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients.
Dubois M, Abi Rached H, Escande A, Dezoteux F, Darloy F, Jouin A, Kyheng M, Labreuche J, Dziwniel V, Mirabel X, Mortier L. Radiat Oncol. 2021 May 14;16(1):90. doi: 10.1186/s13014-021-01815-4. PMID: 33990201

NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N, Kervarrec T, Sohier P, Poirot B, Haffner A, Carlotti A, Balme B, Castillo C, Jullie ML, Osio A, Lehmann-Che J, Frouin E, Battistella M. Am J Surg Pathol. 2021 Sep 1;45(9):1221-1227. doi: 10.1097/PAS.0000000000001693. PMID: 33739783

Reevaluation of GLI1 Expression in Skin Tumors.
Kervarrec T, Berthon P, Thanguturi S, Guyétant S, Macagno N, Jullie ML. Am J Dermatopathol. 2021 Oct 1;43(10):759-761. doi: 10.1097/DAD.0000000000001917. PMID: 33577176

2020

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.
Bharmal M, Nolte S, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Pusceddu S, Hanna GJ, Hassel JC, Kiecker F, Ellers-Lenz B, Bajars M, Güzel G, Nghiem P, Hunger M, Schlichting M, Henry-Szatkowski M, D'Angelo SP. Future Oncol. 2020 Sep;16(27):2089-2099. doi: 10.2217/fon-2020-0426. Epub 2020 Sep 17. PMID: 32938212

p40 expression in Merkel cell carcinoma.
Kervarrec T, Guyétant S, Jullie ML. Hum Pathol. 2020 Jun;100:54-55. doi: 10.1016/j.humpath.2020.03.004. Epub 2020 Mar 28. PMID: 32234323

2019

[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part].
Seris A, Battistella M, Beylot-Barry M, Dalle S, Mortier L, Lebbé C, Blom A, Neidhart-Berard EM, Kramkimel N, Dupuy A, Zehou O, Dalac S, Jullie ML, Cribier B, Jouary T; Pour CARADERM, réseau de cancers rares dermatologiques (www.caraderm.org); le Groupe de cancérologie cutanée de la Société française de dermatologie. Ann Dermatol Venereol. 2019 Nov;146(11):704-710. doi: 10.1016/j.annder.2019.07.006. Epub 2019 Sep 30. PMID: 31582261

2018

Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey.
Fondain M, Dereure O, Uhry Z, Guizard AV, Woronoff AS, Colonna M, Molinie F, Bara S, Velten M, Marrer E, Grosclaude P, Lapôtre-Ledoux B, Tretarre B, Guillot B. J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1292-1296. doi: 10.1111/jdv.14798. Epub 2018 Mar 9. PMID: 29341266

2017

Epidemiological trends in Merkel cell carcinoma in southern France: a registry-based study.
Fondain M, Du Thanh A, Bessaoud F, Dereure O, Tretarre B, Guillot B. Br J Dermatol. 2017 May;176(5):1379-1381. doi: 10.1111/bjd.14950. Epub 2017 Mar 10. PMID: 27515470